annual EBITDA:
-$138.53M-$87.37M(-170.77%)Summary
- As of today (May 29, 2025), VRNA annual EBITDA is -$138.53 million, with the most recent change of -$87.37 million (-170.77%) on December 31, 2024.
- During the last 3 years, VRNA annual EBITDA has fallen by -$83.91 million (-153.63%).
- VRNA annual EBITDA is now -1154308.33% below its all-time high of -$12.00 thousand, reached on December 31, 2005.
Performance
VRNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$6.07M+$8.91M(+59.49%)Summary
- As of today (May 29, 2025), VRNA quarterly EBITDA is -$6.07 million, with the most recent change of +$8.91 million (+59.49%) on March 31, 2025.
- Over the past year, VRNA quarterly EBITDA has increased by +$17.12 million (+73.83%).
- VRNA quarterly EBITDA is now -153.11% below its all-time high of $11.43 million, reached on September 30, 2021.
Performance
VRNA quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$121.41M+$17.12M(+12.36%)Summary
- As of today (May 29, 2025), VRNA TTM EBITDA is -$121.41 million, with the most recent change of +$17.12 million (+12.36%) on March 31, 2025.
- Over the past year, VRNA TTM EBITDA has dropped by -$63.17 million (-108.49%).
- VRNA TTM EBITDA is now -9732.04% below its all-time high of -$1.23 million, reached on June 30, 2016.
Performance
VRNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VRNA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -170.8% | +73.8% | -108.5% |
| 3 y3 years | -153.6% | +75.2% | -108.8% |
| 5 y5 years | -246.5% | +50.0% | -179.9% |
VRNA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -170.8% | at low | at high | +91.0% | -153.7% | +12.4% |
| 5 y | 5-year | -246.5% | at low | -153.1% | +91.0% | -216.2% | +12.4% |
| alltime | all time | <-9999.0% | at low | -153.1% | +91.0% | -9732.0% | +12.4% |
VRNA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$6.07M(-59.5%) | -$121.41M(-12.4%) |
| Dec 2024 | -$138.53M(+170.8%) | -$14.98M(-54.0%) | -$138.53M(+1.2%) |
| Sep 2024 | - | -$32.56M(-52.0%) | -$136.90M(+15.6%) |
| Jun 2024 | - | -$67.79M(+192.3%) | -$118.43M(+103.4%) |
| Mar 2024 | - | -$23.19M(+73.7%) | -$58.23M(+13.8%) |
| Dec 2023 | -$51.16M(-24.0%) | -$13.35M(-5.2%) | -$51.16M(+6.9%) |
| Sep 2023 | - | -$14.09M(+85.4%) | -$47.85M(-2.5%) |
| Jun 2023 | - | -$7.60M(-52.9%) | -$49.07M(-16.7%) |
| Mar 2023 | - | -$16.12M(+60.5%) | -$58.90M(-12.5%) |
| Dec 2022 | -$67.29M(+23.2%) | -$10.04M(-34.4%) | -$67.29M(-16.4%) |
| Sep 2022 | - | -$15.31M(-12.2%) | -$80.51M(+49.7%) |
| Jun 2022 | - | -$17.43M(-28.9%) | -$53.78M(-7.5%) |
| Mar 2022 | - | -$24.51M(+5.3%) | -$58.15M(+6.5%) |
| Dec 2021 | -$54.62M(-15.1%) | -$23.27M(-303.6%) | -$54.62M(-2.4%) |
| Sep 2021 | - | $11.43M(-152.4%) | -$55.96M(-35.0%) |
| Jun 2021 | - | -$21.81M(+4.0%) | -$86.11M(+17.7%) |
| Mar 2021 | - | -$20.97M(-14.8%) | -$73.17M(+13.7%) |
| Dec 2020 | -$64.34M(+60.9%) | -$24.60M(+31.4%) | -$64.34M(+54.4%) |
| Sep 2020 | - | -$18.73M(+111.2%) | -$41.66M(+8.5%) |
| Jun 2020 | - | -$8.87M(-26.9%) | -$38.39M(-11.5%) |
| Mar 2020 | - | -$12.13M(+531.0%) | -$43.38M(+8.9%) |
| Dec 2019 | -$39.98M | -$1.92M(-87.6%) | -$39.83M(-6.3%) |
| Sep 2019 | - | -$15.47M(+11.6%) | -$42.51M(+35.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$13.86M(+61.4%) | -$31.48M(+73.9%) |
| Mar 2019 | - | -$8.58M(+86.2%) | -$18.11M(-43.3%) |
| Dec 2018 | -$30.36M(-10.2%) | -$4.61M(+3.8%) | -$31.96M(-16.8%) |
| Sep 2018 | - | -$4.44M(+826.0%) | -$38.42M(-19.7%) |
| Jun 2018 | - | -$479.40K(-97.9%) | -$47.81M(-9.3%) |
| Mar 2018 | - | -$22.43M(+102.7%) | -$52.70M(+57.7%) |
| Dec 2017 | -$33.79M(+370.2%) | -$11.07M(-20.0%) | -$33.41M(+36.6%) |
| Sep 2017 | - | -$13.83M(+158.0%) | -$24.46M(+84.8%) |
| Jun 2017 | - | -$5.36M(+70.7%) | -$13.24M(+45.3%) |
| Mar 2017 | - | -$3.14M(+47.9%) | -$9.11M(+52.6%) |
| Dec 2016 | -$7.19M(-45.4%) | -$2.12M(-18.7%) | -$5.97M(+55.2%) |
| Sep 2016 | - | -$2.61M(+111.5%) | -$3.85M(+211.5%) |
| Jun 2016 | - | -$1.23M | -$1.23M |
| Dec 2015 | -$13.17M(+126.2%) | - | - |
| Dec 2014 | -$5.82M(+27.0%) | - | - |
| Dec 2013 | -$4.58M(+11.0%) | - | - |
| Dec 2012 | -$4.13M(+45.8%) | - | - |
| Dec 2011 | -$2.83M(-1.4%) | - | - |
| Dec 2010 | -$2.87M(+12.6%) | - | - |
| Dec 2009 | -$2.55M(+18.9%) | - | - |
| Dec 2008 | -$2.15M(-16.2%) | - | - |
| Dec 2007 | -$2.56M(+95.5%) | - | - |
| Dec 2006 | -$1.31M(>+9900.0%) | - | - |
| Dec 2005 | -$12.00K | - | - |
FAQ
- What is Verona Pharma annual EBITDA?
- What is the all time high annual EBITDA for Verona Pharma?
- What is Verona Pharma annual EBITDA year-on-year change?
- What is Verona Pharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for Verona Pharma?
- What is Verona Pharma quarterly EBITDA year-on-year change?
- What is Verona Pharma TTM EBITDA?
- What is the all time high TTM EBITDA for Verona Pharma?
- What is Verona Pharma TTM EBITDA year-on-year change?
What is Verona Pharma annual EBITDA?
The current annual EBITDA of VRNA is -$138.53M
What is the all time high annual EBITDA for Verona Pharma?
Verona Pharma all-time high annual EBITDA is -$12.00K
What is Verona Pharma annual EBITDA year-on-year change?
Over the past year, VRNA annual EBITDA has changed by -$87.37M (-170.77%)
What is Verona Pharma quarterly EBITDA?
The current quarterly EBITDA of VRNA is -$6.07M
What is the all time high quarterly EBITDA for Verona Pharma?
Verona Pharma all-time high quarterly EBITDA is $11.43M
What is Verona Pharma quarterly EBITDA year-on-year change?
Over the past year, VRNA quarterly EBITDA has changed by +$17.12M (+73.83%)
What is Verona Pharma TTM EBITDA?
The current TTM EBITDA of VRNA is -$121.41M
What is the all time high TTM EBITDA for Verona Pharma?
Verona Pharma all-time high TTM EBITDA is -$1.23M
What is Verona Pharma TTM EBITDA year-on-year change?
Over the past year, VRNA TTM EBITDA has changed by -$63.17M (-108.49%)